List view / Grid view
The EMA has announced its support for the International Coalition…
The EMA has announced its support for the International Coalition of Medicines Regulatory Authorities' call for global collaboration in the fight against COVID-19.
The EMA has published its regulatory strategy until 2025, highlighting…
The EMA has published its regulatory strategy until 2025, highlighting that it will use the COVID-19 pandemic to adapt its processes as needed.
The EMA has released a statement on its efforts to…
The EMA has released a statement on its efforts to support the development of a treatment for the novel coronavirus (2019-nCoV).
Ten priority actions have been recommended for the European medicines…
Ten priority actions have been recommended for the European medicines regulatory network to evolve its approach to data use.
The EMA CHMP has given a positive opinion for marketing…
The EMA CHMP has given a positive opinion for marketing authorisation approval to seven medicines following its October meeting.
The FDA and EMA have agreed to rely on each…
The FDA and EMA have agreed to rely on each other’s assessment of pharmaceutical manufacturing sites to reduce duplicative work.
All sponsors of clinical trials conducted in the European Union…
All sponsors of clinical trials conducted in the European Union have been reminded of their obligation to make summaries of trial results.
The EMA will relocate to Amsterdam in the Netherlands. The Agency…
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
